Olfen (Diclofenac Sodium)

Diclofenac sodium works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for prostaglandin production. By lowering prostaglandin levels, the drug diminishes inflammation, pain signaling, and fever, providing its characteristic therapeutic effects.

The appropriate dose of Olfen is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for diclofenac during pregnancy and lactation are limited. It is generally advised to avoid use in the third trimester and to discuss potential risks with a healthcare provider. Breastfeeding mothers should also seek medical advice before using Olfen.

To order Olfen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Olfen (diclofenac) and ibuprofen belong to the same NSAID class but differ in potency and dosing frequency. Diclofenac often provides stronger anti‑inflammatory effects at lower doses, while ibuprofen may be preferred for milder pain. Both share similar gastrointestinal and cardiovascular risk profiles, requiring individualized selection by a clinician.

Olfen should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Olfen is taken orally with a full glass of water. It can be taken with or without food, although taking it with meals may reduce gastrointestinal irritation. Patients should swallow the tablet whole and not crush or chew it unless directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe renal impairment, hepatic injury, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Olfen should be avoided in individuals with known hypersensitivity to diclofenac or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in the third trimester of pregnancy.